Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AmeriCann, Inc. (ACAN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5800-0.0006 (-0.10%)
At close: 03:48PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5806
Open0.5450
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5100 - 0.5900
52 Week Range0.3000 - 1.9900
Volume12,852
Avg. Volume25,185
Market Cap14.034M
Beta (5Y Monthly)1.33
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateDec 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ACAN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AMERICANN INC
    UFPI: Lowering target price to $111.00UFP INDUSTRIES INC has an Investment Rating of BUY; a target price of $111.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    AmeriCann Generates 225% Year-Over-Year Revenue Growth

    Company produced impressive revenue increases from its cannabis real estate assetsBOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) -- AmeriCann Inc. (OTCQB:ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announced that the Company’s year-over-year revenue growth exceeded 225% from the calendar year of 2020 to 2021. The increase in financial performance is attributable to greater revenue received from products produced

  • GlobeNewswire

    AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report

    Dr. Sanjay Gupta’s Award-winning Series WEED 6: Marijuana and Autism Will Broadcast Again on Friday, Dec. 24 at 6 P.M. ESTBOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AmeriCann Inc. (OTCQB:ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announced that the Company’s Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments

  • GlobeNewswire

    AmeriCann Reports Record Quarter and Fiscal Year-End Financial Results

    The Company achieved positive quarterly net income and substantial EBITDA growth BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, released financial and operational results for its fiscal year and quarter ending September 2021. Financial Overview The Company achieved four consecutive quarters of increased operating revenue, c

Advertisement
Advertisement